Author:
Hartenfeller Markus,Schneider Gisbert
Reference82 articles.
1. Danziger, D. J. and Dean, P. M. (1989) Automated site-directed drug design: a general algorithm for knowledge acquisition about hydrogen-bonding regions at protein surfaces. Proc R Soc Lond B Biol Sci
236, 101–13.
2. Schneider, G. and Fechner, U. (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov
4, 649–63.
3. Mauser, H. and Guba, W. (2008) Recent developments in de novo design and scaffold hopping. Curr Opin Drug Discov Devel
11, 365–74.
4. Nikitin, S., Zaitseva, N., Demina, O., Solovieva, V., Mazin, E., Mikhalev, S., Smolov, M., Rubinov, A., Vlasov, P., Lepikhin, D., Khachko, D., Fokin, V., Queen, C., and Zosimov, V. (2005) A very large diversity space of synthetically accessible compounds for use with drug design programs. J Comput Aided Mol Des
19, 47–63.
5. Douguet, D., Munier-Lehmann H., Labesse G., and Pochet S. (2005) LEA3D: a computer-aided ligand design for structure-based drug design. J Med Chem
48, 2457–68.
Cited by
133 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献